Matthew M. Coggin serves as Senior Vice President, Business Development and Strategy Officer of the Company. Mr. Coggin joined the Company in March 2019 and has served as Senior Vice President, Business Development and Strategy Officer since May 2019. He has close to two decades of experience in the dental space and corporate development. With more than 18 years of experience in the medical industry, Mr. Coggin’s experience ranges from the investment side to the commercialization of medical device and pharmaceutical products. For the greater part of his career, he has worked with specialized drug delivery and diagnostic opportunities ranging from microsphere technology to dynamic radiology and imaging. From 2010 to March 2019, he held various sales and leadership positions within OraPharma, a specialty pharmaceutical company focusing on the dental industry within the Bausch Health organization. Prior to joining the Company, Mr. Coggin, served as Vice President and General Manager of OraPharma from August 2016 to April 2019 and was responsible for all commercialization, strategy and business development for the U.S. and international business. Prior to joining OraPharma, he served as an associate in private equity and venture capital focusing on healthcare. Mr. Coggin holds a bachelor’s degree in Biomedical Engineering from the Johns Hopkins University.
Matthew Coggin is 41, he's been the Senior Vice President e Business Development and Strategy Officer of DENTSPLY Sirona Inc since 2019. There are 27 older and no younger executives at DENTSPLY Sirona Inc. The oldest executive at DENTSPLY Sirona Inc is Francis Lunger, 74, who is the Independent Director.
Matthew's mailing address filed with the SEC is C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277.
Over the last 16 years, insiders at DENTSPLY Sirona Inc have traded over $24,077,738 worth of DENTSPLY Sirona Inc stock and bought 304,106 units worth $15,867,209 . The most active insiders traders include Nicholas W Alexos, Gregory T Lucier, eBret W Wise. On average, DENTSPLY Sirona Inc executives and independent directors trade stock every 19 days with the average trade being worth of $439,996. The most recent stock trade was executed by Gregory T Lucier on 8 August 2024, trading 8,212 units of XRAY stock currently worth $199,962.
a global total solutions provider dentsply sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products. dentsply sirona is one global team that brings out the best in our people, lives and breathes high performance and personal accountability, acts with uncompromising integrity, improves the practice of dentistry with an unrelenting commitment to our customers and demonstrates a passion for innovation that shapes the dental industry. as the dental solutions company™, dentsply sirona provides dental professionals a comprehensive end-to-end solutions offering. this offering includes some of the best-known and established brands in the industry. we develop, manufacture and market a complete line of dental and oral health products, including gener
DENTSPLY Sirona Inc executives and other stock owners filed with the SEC include: